Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
2019 · Clinical Cancer Research · 106 citations
https://doi.org/10.1158/1078-0432.ccr-19-0353
G
Gemma Fuster
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
110
Papers
2.1K
Citations
24
h-index
32
i10-index
Gemma Fuster is an academic researcher from Universitat de Vic - Universitat Central de Catalunya. The author has contributed to research in topics: Cancer Cells and Metastasis & Fibroblast Growth Factor Research & Cancer, Hypoxia, and Metabolism. The author has an h-index of 24, co-authored 94 publications.
ORCID: 0000-0002-4501-2422Papers by this author
worksSubstance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer
2013 · Cancer Research · 98 citations
https://doi.org/10.1158/0008-5472.can-12-4573
Injurious mechanical ventilation affects neuronal activation in ventilated rats
2011 · Critical Care · 88 citations
https://doi.org/10.1186/cc10230
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
2018 · Breast Cancer Research · 29 citations
https://doi.org/10.1186/s13058-018-0977-z
In Vitro and In Vivo Effects of the Combination of Polypurine Reverse Hoogsteen Hairpins against HER-2 and Trastuzumab in Breast Cancer Cells
2023 · International Journal of Molecular Sciences · 5 citations
https://doi.org/10.3390/ijms24087073
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma
2024 · Breast Cancer Research · 2 citations
https://doi.org/10.1186/s13058-024-01871-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat